Clinical trials are both a treatment option for all types of patients and the core way that new advances are made in MDS care. Learn more about these clinical trials.
Early responses from the ven/aza combination treatment provided an effective avenue for patients to receive a stem cell transplant.
Imetelstat and low risk mds, life with mds, mds clinical trial, imetelstat and transfusions, transfusion independence
Gilead announced they would be discontinuing their Phase 3 ENHANCE study, which was looking at Magrolimab in High-Risk MDS (HR-MDS) patients.
Can Selinexor improve blood counts and bone marrow function in MDS patients?
Patients with intermediate-, high-, or very-high-risk myelodysplastic syndrome (MDS) need durable treatment options with favorable tolerability.